In cardiovascular diseases, Smad3 is pathogenic as deletion of Smad3 protects against cardiovascular inflammation and fibrosis under various pathological conditions such as hypertension, myocardial infarction and obese diabetes.6, 7, 8, 9, 10. This evidence concerns the gene SMAD3 and myocardial infarction.